Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan

Tze‐Fan Chao; Chern-En Chiang; Yenn‐Jiang Lin; Shih‐Lin Chang; Li‐Wei Lo; Yu‐Feng Hu; Ta‐Chuan Tuan; Jo‐Nan Liao; Fa‐Po Chung; Tzeng‐Ji Chen; Professor Gregory Lip; Shih‐Ann Chen

doi:10.1161/circulationaha.118.036046

Back

Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan

Letter 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Non–Vitamin K Antagonist Oral Anticoagulants in Elderly (≥85 years) Patients With Newly Diagnosed Atrial Fibrillation

Wen‐Han Cheng, Chern-En Chiang, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen, Tze‐Fan Chao

Article2022

Development of Interstitial Lung Disease Among Patients With Atrial Fibrillation Receiving Oral Anticoagulants in Taiwan

Yi‐Hsin Chan, Tze‐Fan Chao, Shao‐Wei Chen, Hsin‐Fu Lee, Wei-Min Chen, Pei‐Ru Li, Yung‐Hsin Yeh, Chi‐Tai Kuo, Lai‐Chu See, Professor Gregory Lip

Article2018

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Tatjana Potpara, Charles J. Ferro, Professor Gregory Lip

Article2023

Cardiac and renal outcomes of direct oral anticoagulants in patients with atrial fibrillation

Yuting Wang, Jo‐Hsin Chen, Shu‐Fen Liao, Yu‐Jen Chen, Professor Gregory Lip, Jong‐Shiuan Yeh

Preprint2023

Cardiorenal Outcomes of Treatment with Direct Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation

Yuting Wang, Jo-Hsin Chen, Shu-Fen Liao, Yu-Jen Chen, Professor Gregory Lip, Jong-Shiuan Yeh